Literature DB >> 16142495

[Embolia cutis medicamentosa after subcutaneous injection of pegylated interferon-alpha].

M Sonntag1, N Hodzic-Avdagic, D Bruch-Gerharz, N J Neumann.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16142495     DOI: 10.1007/s00105-005-1026-2

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


× No keyword cloud information.
  5 in total

1.  Nicolau syndrome following diclofenac administration.

Authors:  K Ezzedine; J Vadoud-Seyedi; M Heenen
Journal:  Br J Dermatol       Date:  2004-02       Impact factor: 9.302

2.  [Aseptic skin necrosis after subcutaneous injection of alpha interferon].

Authors:  H Rasokat; C Bendick; U Wemmer; G K Steigleder
Journal:  Dtsch Med Wochenschr       Date:  1989-03-24       Impact factor: 0.628

3.  [Embolia cutis medicamentosa (Nicolau syndrome) after intra-articular injection].

Authors:  S Beissert; D Presser; A Rütter; D Metze; T A Luger; T Schwarz
Journal:  Hautarzt       Date:  1999-03       Impact factor: 0.751

4.  [Atypical zosteriform segmental embolia cutis medicamentosa].

Authors:  L D Köhler; W I Worret; H Hofmann
Journal:  Hautarzt       Date:  1997-07       Impact factor: 0.751

5.  Embolia cutis medicamentosa of the foot after sclerotherapy.

Authors:  J Geukens; E Rabe; T Bieber
Journal:  Eur J Dermatol       Date:  1999-03       Impact factor: 3.328

  5 in total
  3 in total

1.  Nicolau syndrome: an iatrogenic cutaneous necrosis.

Authors:  Kc Nischal; Hb Basavaraj; Mr Swaroop; Dp Agrawal; Bd Sathyanarayana; Np Umashankar
Journal:  J Cutan Aesthet Surg       Date:  2009-07

2.  Recurrent Nicolau syndrome associated with subcutaneous glatiramer acetate injection--a case report.

Authors:  Chiara Zecca; Carlo Mainetti; Roland Blum; Claudio Gobbi
Journal:  BMC Neurol       Date:  2015-12-02       Impact factor: 2.474

3.  Case Report: Nicolau syndrome due to etofenamate injection.

Authors:  Emin Ozlu; Aysegul Baykan; Ragıp Ertas; Yılmaz Ulas; Kemal Ozyurt; Atıl Avcı; Halit Baykan
Journal:  F1000Res       Date:  2017-06-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.